Marta Barisella

2.0k total citations
60 papers, 1.2k citations indexed

About

Marta Barisella is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Marta Barisella has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 23 papers in Oncology and 18 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Marta Barisella's work include Sarcoma Diagnosis and Treatment (41 papers), Cardiac tumors and thrombi (18 papers) and Vascular Tumors and Angiosarcomas (12 papers). Marta Barisella is often cited by papers focused on Sarcoma Diagnosis and Treatment (41 papers), Cardiac tumors and thrombi (18 papers) and Vascular Tumors and Angiosarcomas (12 papers). Marta Barisella collaborates with scholars based in Italy, United States and United Kingdom. Marta Barisella's co-authors include Alessandro Gronchi, Paolo G. Casali, Paola Collini, Marco Fiore, Silvia Stacchiotti, Rosalba Miceli, Carlo Morosi, Roberta Sanfilippo, Luigi Mariani and Claudia Sangalli and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Radiology.

In The Last Decade

Marta Barisella

52 papers receiving 1.2k citations

Peers

Marta Barisella
Vaiyapuri P. Sumathi United Kingdom
Marta Barisella
Citations per year, relative to Marta Barisella Marta Barisella (= 1×) peers Vaiyapuri P. Sumathi

Countries citing papers authored by Marta Barisella

Since Specialization
Citations

This map shows the geographic impact of Marta Barisella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Barisella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Barisella more than expected).

Fields of papers citing papers by Marta Barisella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Barisella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Barisella. The network helps show where Marta Barisella may publish in the future.

Co-authorship network of co-authors of Marta Barisella

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Barisella. A scholar is included among the top collaborators of Marta Barisella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Barisella. Marta Barisella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barresi, Sabina, Sabrina Rossi, Evelina Miele, et al.. (2025). EGFRKDD Myofibroblastic Neoplasm or Congenital Peribronchial Myofibroblastic Tumor (CPMT)? Report of a Congenital Myofibroblastic Neoplasm With Unusual Histologic Features. Genes Chromosomes and Cancer. 64(4). e70032–e70032.
2.
Tseng, William W., Francesco Barretta, Marta Barisella, et al.. (2024). Pleomorphic Liposarcoma of the Extremity and Trunk: Multimodality Therapy for Some but Not All?. Journal of Surgical Oncology. 131(2). 291–297.
3.
Stacchiotti, Silvia, Giacomo Giulio Baldi, Anna Maria Frezza, et al.. (2023). Regorafenib in advanced solitary fibrous tumour: Results from an exploratory phase II clinical study. European Journal of Cancer. 195. 113391–113391. 8 indexed citations
4.
Zuco, Valentina, Sandro Pasquali, Monica Tortoreto, et al.. (2023). Effectiveness of irinotecan plus trabectedin on a desmoplastic small round cell tumor patient-derived xenograft. Disease Models & Mechanisms. 16(6). 5 indexed citations
6.
Pasquali, Sandro, Marta Barisella, Marco Fiore, et al.. (2023). Organ Infiltration and Patient Risk After Multivisceral Surgery for Primary Retroperitoneal Liposarcomas. Annals of Surgical Oncology. 30(7). 4500–4510. 9 indexed citations
7.
Fiore, Marco, Silva Ljevar, Sandro Pasquali, et al.. (2022). Preoperative Neutrophil-to-Lymphocyte Ratio and a New Inflammatory Biomarkers Prognostic Index for Primary Retroperitoneal Sarcomas: Retrospective Monocentric Study. Clinical Cancer Research. 29(3). 614–620. 19 indexed citations
8.
Baldi, Giacomo Giulio, Salvatore Lo Vullo, Giovanni Grignani, et al.. (2022). Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case‐series analysis from the Italian Rare Cancers Network. Cancer. 128(7). 1439–1448. 7 indexed citations
9.
Radaelli, Stefano, Sandro Pasquali, Chiara Colombo, et al.. (2022). Treatment strategies and outcomes of primary Myxofibrosarcomas in a large patients cohort. European Journal of Surgical Oncology. 48(8). 1723–1729. 13 indexed citations
10.
Spolverato, Gaya, Giulia Lorenzoni, Marco Fiore, et al.. (2021). Oncological outcomes after major vascular resections for primary retroperitoneal liposarcoma. European Journal of Surgical Oncology. 47(12). 3004–3010. 16 indexed citations
11.
Tseng, William W., Francesco Barretta, Marco Baia, et al.. (2021). Dedifferentiation within well‐differentiated liposarcoma of the extremity or trunk: Implications for clinical management. Journal of Surgical Oncology. 124(5). 838–845. 4 indexed citations
12.
Fabbroni, Chiara, Giovanni Fucà, Francesca Ligorio, et al.. (2021). Impact of Pathological Stratification on the Clinical Outcomes of Advanced Well-Differentiated/Dedifferentiated Liposarcoma Treated with Trabectedin. Cancers. 13(6). 1453–1453. 14 indexed citations
13.
Tazzari, Marcella, Laura Bergamaschi, Alessandro De Vita, et al.. (2021). Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention. International Journal of Molecular Sciences. 22(14). 7518–7518. 23 indexed citations
14.
Perhavec, Andraž, Salvatore Provenzano, Marco Baia, et al.. (2020). Inoperable Primary Retroperitoneal Sarcomas: Clinical Characteristics and Reasons Against Resection at a Single Referral Institution. Annals of Surgical Oncology. 28(2). 1151–1157. 14 indexed citations
15.
Tirotta, Fabio, Carlo Morosi, James Hodson, et al.. (2020). Improved Biopsy Accuracy in Retroperitoneal Dedifferentiated Liposarcoma. Annals of Surgical Oncology. 27(11). 4574–4581. 9 indexed citations
16.
Tirotta, Fabio, Elena Fumagalli, Chiara Colombo, et al.. (2019). Management of complicated tumor response to tyrosine‐kinase inhibitors in gastrointestinal stromal tumors. Journal of Surgical Oncology. 120(2). 256–261. 1 indexed citations
17.
Almond, Max, Fabio Tirotta, Hannah L. Tattersall, et al.. (2019). Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma. British journal of surgery. 106(4). 395–403. 31 indexed citations
18.
Fiore, Marco, Chiara Colombo, Stefano Radaelli, et al.. (2015). Hormonal manipulation with toremifene in sporadic desmoid-type fibromatosis. European Journal of Cancer. 51(18). 2800–2807. 51 indexed citations
19.
Barisella, Marta, Andrea Lampis, Federica Perrone, & Antonino Carbone. (2008). Clear cell adenocarcinoma of the colon is a unique morphological variant of intestinal carcinoma: Case report with molecular analysis. World Journal of Gastroenterology. 14(42). 6575–6575. 14 indexed citations
20.
Pelosi, Giuseppe, Marta Barisella, Felice Pasini, et al.. (2004). CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients. Modern Pathology. 17(6). 711–721. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026